LifeMD (LFMD) Net Income towards Common Stockholders (2012 - 2025)
LifeMD's (LFMD) quarterly Net Income towards Common Stockholders came in at -$5.4 million in Q4 2025, up 27.83% on a YoY basis from -$4.2 million in Q4 2024, and down 17.82% quarter-over-quarter from -$4.6 million in Q3 2025.
Powered by 
Analysis
LifeMD (LFMD) Net Income towards Common Stockholders (2012 - 2025) Analysis & Trends
LifeMD (LFMD) has reported Net Income towards Common Stockholders for 14 consecutive years, with -$5.4 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 27.83% year-over-year to -$5.4 million; the trailing twelve-month figure through Dec 2025 stood at -$13.3 million (up 52.55% YoY), and the FY2025 full-year result was -$13.3 million, up 49.25% from the prior year.
- Net Income towards Common Stockholders declined to -$5.4 million in Q4 2025 per LFMD's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$960341.0 in Q1 2025 and bottomed at -$19.0 million in Q4 2021.
- Historically, Net Income towards Common Stockholders has averaged -$8.8 million across 5 years, with a median of -$7.5 million in 2023.
- The sharpest annual moves came in 2021 and 2025: Net Income towards Common Stockholders slumped 398.08% in 2021, then jumped 87.27% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$19.0 million in 2021, then jumped by 33.03% to -$12.7 million in 2022, then soared by 64.53% to -$4.5 million in 2023, then sank by 65.94% to -$7.5 million in 2024, then climbed by 27.83% to -$5.4 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$5.4 million, -$4.6 million, and -$2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn | 43.10 Mn |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn | -86.29 Mn |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn | 19.53 Mn |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn | 5.29 Mn |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn | -38.91 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | -1.52 Mn |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - | -37.51 Mn |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 | -1.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.40 Mn |
| Sep 30, 2025 | -4.58 Mn |
| Jun 30, 2025 | -2.40 Mn |
| Mar 31, 2025 | -960,341.00 |
| Dec 31, 2024 | -7.48 Mn |
| Sep 30, 2024 | -5.43 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Mar 31, 2024 | -7.54 Mn |
| Dec 31, 2023 | -4.51 Mn |
| Sep 30, 2023 | -6.90 Mn |
| Jun 30, 2023 | -7.51 Mn |
| Mar 31, 2023 | -4.79 Mn |
| Dec 31, 2022 | -12.71 Mn |
| Sep 30, 2022 | -8.06 Mn |
| Jun 30, 2022 | -13.80 Mn |
| Mar 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | -18.98 Mn |
| Sep 30, 2021 | -14.35 Mn |
| Jun 30, 2021 | -16.83 Mn |
| Mar 31, 2021 | -11.60 Mn |